Table 1.
Demographics and clinical characteristics
| BED (n = 41) | |
|---|---|
| Age, years M (SD) | 26.6 (5.5) |
| Sex, n (%) | |
| Female | 40 (97.6) |
| Race or ethnicity, n (%) | |
| Aboriginal and/or Torres Strait Islander | 2 (4.9) |
| Asian | 7 (17.1) |
| Caucasian | 22 (53.7) |
| Hispanic | 0 (0) |
| Other or multiple | 10 (24.4) |
| Length of illness, years M (SD) | 11.0 (7.6) |
| BMI category, n (%) | |
| Normal (19–25.0 kg/m2) | 13 (31.7) |
| Overweight (≥ 25.0 to < 30.0 kg/m2) | 16 (39.0) |
| Obesity Class I (≥ 30.0 to < 35.0 kg/m2) | 8 (19.5) |
| Obesity class II (≥ 35.0 to < 40.0 kg/m2) | 3 (7.3) |
| Obesity Class III (≥ 40.0 kg/m2) | 1 (2.4) |
| Current psychiatric comorbidities, n (%) | |
| MDD | 5 (12.2) |
| Anxiety | 5 (12.2) |
| AUD/SUD | 7 (17.1) |
| ADHD | 5 (12.2) |
| Concurrent medication (class), n (%) | |
| SSRI | 4 (9.8) |
| Anticonvulsant | 2 (4.9) |
| Anxiolytic | 2 (4.9) |
| Anti-diabetic | 2 (4.9) |
| Proton-pump inhibitor | 1 (2.4) |
| Diuretic | 1 (2.4) |
| Thyroxine | 1 (2.4) |
| Contraceptive | 11 (26.8) |
M mean, SD standard deviation, n number, BMI body mass index, MDD major depressive disorder, AUD alcohol use disorder, SUD substance use disorder, ADHD attention deficit hyperactivity disorder
*Anxiety includes Generalised Anxiety Disorder, Social Anxiety and Panic Disorder